Value-Based Generic Drug Evaluation Focus on Chinese Real-World Evidence

Document Type : Letter to Editor

Authors

1 Department of Clinical Pharmacy, National Children’s Medical Center, Children’s Hospital of Fudan University, Shanghai, China

2 NHC Key Laboratory of Health Technology Assessment, Department of Health Economics, School of Public Health, Fudan University, Shanghai, China

Keywords


Dear Editor,

Increased use of cheap generics could lead to significant savings in drug spending. In the United States, generics make up 90% of all drugs. More than 95% of China’s 170 000 drugs are generic. Meanwhile, there is a broad class of generic drugs called me-too drugs. More than 60% of the Essential Medicines on the World Health Organization (WHO) list are me-too drugs.1 After generics replace branded drugs, we face an impossible trinity. Impossible Trinity refers to drug policy’s difficulty in achieving three objectives (high quality, low price, and adequate supply) simultaneously.2 .... (Read more...)

  1. Aronson JK, Green AR. Me-too pharmaceutical products: history, definitions, examples, and relevance to drug shortages and essential medicines lists. Br J Clin Pharmacol. 2020;86(11):2114-2122. doi:1111/bcp.14327
  2. Hemel DJ, Ouellette LL. The generic drug trilemma. In: Entrepreneurship and Innovation Policy and the Economy. National Bureau of Economic Research; 2022.
  3. Notice of Comprehensive Clinical Evaluation of Drugs. 2021. http://www.nhc.gov.cn/yaozs/s2908/202107/532e20800a47415d84adf3797b0f4869.shtml.
  4. Albarqouni L, Palagama S, Chai J, et al. Overuse of medications in low- and middle-income countries: a scoping review. Bull World Health Organ. 2023;101(1):36-61D. doi:2471/blt.22.288293
  5. Mühlbacher AC, Kaczynski A. Making good decisions in healthcare with multi-criteria decision analysis: the use, current research and future development of MCDA. Appl Health Econ Health Policy. 2016;14(1):29-40. doi:1007/s40258-015-0203-4

Articles in Press, Corrected Proof
Available Online from 22 August 2023
  • Receive Date: 13 February 2023
  • Revise Date: 16 August 2023
  • Accept Date: 21 August 2023
  • First Publish Date: 22 August 2023